Clinical Trial


Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence


Brief description

The purpose of the study is long-term safety, tolerability and efficacy of nalmefene in patients with alcohol dependence.

Detailed Description

Alcohol dependence is a maladaptive pattern of alcohol use, leading to clinically significant impairment or distress, as manifested by at least three of a number of criteria such as tolerance, withdrawal symptoms, frequent use of alcohol in larger amounts or over longer periods than was intended, and others. Excessive intake of alcohol reduces the life span by a decade, and alcohol drinking is strongly related to mortality from liver cirrhosis, chronic pancreatitis, certain cancers, hypertension, accidents and violence. This study is planned to evaluate the long-term safety and tolerability as well as to evaluate the efficacy of as needed use of 18.06 mg nalmefene in patients with alcohol dependence.

Keywords

  •   Alcohol Dependence

Sponsored By

H. Lundbeck A/S

Unique Study ID

NCT00811941

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

Teva Pharmaceutical Industries
412 01, Litomerice, Czechia
Distance from Current Trial is 0 miles

No Investigator Listed

Pfizer
412 01, Litomerice, Czechia
Distance from Current Trial is 0 miles

No Investigator Listed

AstraZeneca
412 01, Litomerice, Czechia
Distance from Current Trial is 0 miles
View All